Literature DB >> 16042772

Zollinger-Ellison syndrome associated with neurofibromatosis type 1: a case report.

Wan-Sik Lee1, Yang-Seok Koh, Jung-Chul Kim, Chang-Hwan Park, Young-Eun Joo, Hyun-Soo Kim, Chol-Kyoon Cho, Sung-Kyu Choi, Jong-Sun Rew, Sei-Jong Kim.   

Abstract

BACKGROUND: Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder with characteristic features of skin and central nervous system involvement. Gastrointestinal involvement is rare, but the risk of malignancy development is considerable. Zollinger-Ellison syndrome is caused by gastrin-secreting tumors called gastrinomas. Correct diagnosis is often difficult, and curative treatment can only be achieved surgically. CASE
PRESENTATION: A 41-year-old female affected by neurofibromatosis type 1 presented with a history of recurrent epigastric soreness, diarrhea, and relapsing chronic duodenal ulcer. Her serum fasting gastrin level was over 1000 pg/mL. An abdominal CT scan revealed a 3 x 2-cm, well-enhanced mass adjacent to the duodenal loop. She was not associated with multiple endocrine neoplasia type 1. Operative resection was performed and gastrinoma was diagnosed by immunohistochemical staining. The serum gastrin level decreased to 99.1 pg/mL after surgery, and symptoms and endoscopic findings completely resolved without recurrences.
CONCLUSION: Gastrinoma is difficult to detect even in the general population, and hence symptoms such as recurrent idiopathic peptic ulcer and diarrhea in neurofibromatosis type 1 patients should be accounted for as possibly contributing to Zollinger-Ellison syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16042772      PMCID: PMC1181810          DOI: 10.1186/1471-2407-5-85

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  29 in total

Review 1.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Authors:  D H Gutmann; A Aylsworth; J C Carey; B Korf; J Marks; R E Pyeritz; A Rubenstein; D Viskochil
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

2.  Abdominal tumours and neurofibromatosis.

Authors:  A J Martin; R C Williamson
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

3.  Gastrointestinal involvement in von Recklinghausen's neurofibromatosis.

Authors:  F H Hochberg; A B Dasilva; J Galdabini; E P Richardson
Journal:  Neurology       Date:  1974-12       Impact factor: 9.910

Review 4.  Epidemiology of neurofibromatosis type 1.

Authors:  J M Friedman
Journal:  Am J Med Genet       Date:  1999-03-26

5.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

Review 6.  Ampullary adenocarcinoma in neurofibromatosis type 1. Case report and literature review.

Authors:  R Costi; P Caruana; L Sarli; V Violi; L Roncoroni; C Bordi
Journal:  Mod Pathol       Date:  2001-11       Impact factor: 7.842

Review 7.  Duodenal gastrinoma: the solution to the pancreatic paradox.

Authors:  I M Modlin; G P Lawton
Journal:  J Clin Gastroenterol       Date:  1994-10       Impact factor: 3.062

Review 8.  Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease).

Authors:  C E Fuller; G T Williams
Journal:  Histopathology       Date:  1991-07       Impact factor: 5.087

9.  [Recklinghausen's disease with digestive localizations associated with gastric acid hypersecretion suggesting Zollinger-Ellison syndrome].

Authors:  J P Chagnon; J Barge; D Hénin; D Blanc
Journal:  Gastroenterol Clin Biol       Date:  1985-01

10.  Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.

Authors:  M Zöller; B Rembeck; H O Akesson; L Angervall
Journal:  Acta Derm Venereol       Date:  1995-03       Impact factor: 4.437

View more
  8 in total

Review 1.  Genetics of pancreatic neuroendocrine tumors: implications for the clinic.

Authors:  Antonio Pea; Ralph H Hruban; Laura D Wood
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-28       Impact factor: 3.869

Review 2.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

Review 3.  Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-06       Impact factor: 4.690

Review 4.  Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.

Authors:  Jordan M Cloyd; George A Poultsides
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 5.  Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.

Authors:  Abbas Agaimy; Nikolaos Vassos; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

6.  Pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case Report and Literature Review.

Authors:  Arif A Arif; Peter T W Kim; Adrienne Melck; Andrew Churg; Zachary Schwartz; Heather C Stuart
Journal:  Am J Case Rep       Date:  2021-01-16

Review 7.  Gastrinoma and neurofibromatosis type 2: the first case report and review of the literature.

Authors:  Sara Massironi; Alessandra Zilli; Roberta Elisa Rossi; Federica Cavalcoli; Dario Conte; Maddalena Peracchi
Journal:  BMC Gastroenterol       Date:  2014-06-24       Impact factor: 3.067

Review 8.  Zollinger-Ellison Syndrome Associated with von Recklinghausen Disease: Case Report and Literature Review.

Authors:  Mohamad J Alshikho; Salem I Noureldine; Joud M Talas; Antoine Nasimian; Safi Zazou; Bashir Mobaed; Mahmoud Nasser
Journal:  Am J Case Rep       Date:  2016-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.